Business Context and Reporting Period
This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of February 2018. The report was signed by Zhang Qisen (Johnson), Chief Financial Officer, on February 13, 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing includes a press release as Exhibit 99.1.
Financial Metrics
The provided filing text does not contain specific financial data. There are no disclosed values for revenue, profit, cash flow, margins, debt, or liquidity within this document.
Material Changes
The filing text does not provide information regarding material changes versus the prior comparable period.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. The document serves primarily as a cover sheet referencing an external press release.
Key Facts for Investor Verification
- The registrant is Hexindai Inc., not Akso Health Group as indicated in the request metadata.
- The filing contains no financial figures; investors must review the attached Exhibit 99.1 (Press Release) for substantive information.
- The report was filed for the month of February 2018 but signed on February 13, 2018.